Geovax Labs Inc (GOVXW)

概要ニュース株価時系列ディスカッション予測

Geovax Labs Inc (GOVXW) 最新ニュース

Geovax Labs Inc (GOVXW)

Geovax Labs Inc (GOVXW) 最新ニュース

Stock Surge: Geovax Labs Inc (GOVX) Closes at 1.77, Marking a -7.33 Increase/Decrease - The Dwinnex

Analysts review Geovax Labs Inc’s rating - Knox Daily

GeoVax to Present Strategic Vision for Cancer and Infectious Disease Treatments at Major Biotech Conference - Citybuzz

GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor Conference - Yahoo Finance

Trump's Stargate Initiative: A New Era For Healthcare Innovation - Evrim Ağacı

GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative - Yahoo Finance

GeoVax Labs’ (GOVX) “Buy” Rating Reiterated at D. Boral Capital - Defense World

GeoVax Labs (NASDAQ:GOVXW) Shares Down 11.3% – Here’s Why - Defense World

GeoVax shareholders approve warrant exercises - MSN

Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine Capability - Yahoo Finance

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide - Yahoo Finance

GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Average Recommendation of “Buy” from Analysts - Defense World

GeoVax Labs Stockholders Approve Warrant Exercise Proposals - Defense World

GeoVax shareholders approve warrant exercises By Investing.com - Investing.com Australia

D. Boral Capital Reaffirms “Buy” Rating for GeoVax Labs (NASDAQ:GOVX) - Defense World

GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial - Yahoo Finance

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now - GlobeNewswire Inc.

GeoVax Achieves Significant Progress in Next-Generation COVID-19 Vaccine Development Throughout 2024 - Yahoo Finance

GeoVax to Review 2024 Progress at the Emerging Growth Conference on January 16, 2025 - Yahoo Finance

Contrasting GeoVax Labs (NASDAQ:GOVX) & Silverback Therapeutics (NASDAQ:SBTX) - Defense World

GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

GeoVax adjourns Special Meeting due to low quorum - Investing.com

GeoVax adjourns Special Meeting due to low quorum By Investing.com - Investing.com Australia

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - The Manila Times

GeoVax Labs Secures Key Cancer Vaccine Patent, Reports Breakthrough 100% Tumor Prevention Data - StockTitan

GeoVax Labs (GOVX) Price Target Increased by 1170.83% to 77.78 - MSN

GeoVax Labs, Inc. (NASDAQ:GOVX) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Geovax Labs (FRA:E8LA) Days Inventory : 0.00 (As of Sep. 2024) - GuruFocus.com

Geovax Labs (STU:E8LA) Forward Dividend Yield % : 0.00% (As of Nov. 30, 2024) - GuruFocus.com

Alliance Global Partners Initiates Coverage of GeoVax Labs (GOVX) with Buy Recommendation - MSN

3 Penny Stocks Ready to Break Out in 2025 - sharewise

Geovax Labs (STU:E8LA) Momentum Rank : 5 (As of Nov. 27, 2024) - GuruFocus.com

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewswire

GeoVax CEO to Present COVID-19 Vaccine & Cancer Therapy Updates at NobleCon20 | GOVX Stock News - StockTitan

GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks - MSN

Q4 EPS Estimates for GeoVax Labs Lifted by Noble Financial - Defense World

GeoVax Announces Positive Interim Data Review for Phase 2 - GlobeNewswire

GeoVax regains compliance with Nasdaq listing standards By Investing.com - Investing.com Australia

GeoVax regains compliance with Nasdaq listing standards - Investing.com India

GeoVax reports progress in CLL vaccine booster trial - Investing.com India

GeoVax reports progress in CLL vaccine booster trial By Investing.com - Investing.com Canada

GeoVax Labs announces interim data from Phase 2 trial of Vaccine technology - TipRanks

GeoVax's COVID Booster Shows Promise in Leukemia Patients, Outperforms mRNA Vaccine | GOVX Stock News - StockTitan

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia - The Manila Times

Analysts Set Expectations for GeoVax Labs FY2024 Earnings - Defense World

Earnings call: GeoVax reports progress in vaccine trials, financial updates By Investing.com - Investing.com Australia

GOVXWに似た銘柄